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BACKGROUND 
 
Tropical AKI refers to the acute kidney injury occurring in 
association with diseases which are particularly prevalent in tropical 
countries.  
Early recognition and management of these predominantly 
infectious or toxin mediated diseases prevents progression of AKI. 
Immediate mortality as well as future development of chronic 
kidney disease may be largely prevented 
Tropical nephropathies may be broadly classified into 
 Infective  
 Toxic. 
Infections leading to AKI may be  
 Bacteria 
 Viral 
 Protozoal.  
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Among bacteria, the commonly encountered infections are typhoid, 
leptospirosis, gram negative septicemia, tetanus and acute dysentry with 
severe dehydration.  
The common viral offenders are dengue virus, hepatitis virus and  
enterovirus.  
Malaria, kalaazar and filiariasis are the common tropical protozoal 
offenders which may lead to AKI.  
The toxins leading to AKI are 
 Scorpion sting and  
 Snake bite.  
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AIMS AND OBJECTIVES 
AIMS: 
• To study the Immediate outcome and proportion of AKI in children 
admitted with acute febrile illness/envenomation. 
• To study the clinicopathological spectrum and biochemical profile 
of AKI in children admitted with acute febrile illnesses or 
envenomation.  
OBJECTIVES:  
To find 
• Proportion of Tropical AKI in children hospitalized at an urban 
referral hospital 
• Etiological profile of Tropical AKI  in children 
• Clinicopathological spectrum of AKI in children 
• Immediate Outcome of children with tropical AKI 
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REVIEW OF LITERATURE 
 
Rationale for a guideline on AKI is a global problem and occurs in 
the community, in the hospital where it is common on medical, surgical, 
paediatric, and oncology wards, and in ICUs. Irrespective of its nature, 
AKI is a predictor of immediate and long-term adverse outcomes. 
AKI is more prevalent in (and a significant risk factor for) patients 
with chronic kidney disease (CKD). Individuals with CKD are especially 
susceptible to AKI which, in turn, may act as a promoter of progression 
of the Underlying CKD. 
The burden of AKI may be most significant in developing 
countries with limited resources for the care of these patients once the 
disease progresses to kidney failure necessitating RRT. 
Addressing the unique circumstances and needs of developing 
countries, especially in the detection of AKI in its early and potentially 
reversible stages to prevent its progression to kidney failure requiring 
dialysis, is of paramount importance. 
Research over the past decade has identified numerous preventable 
risk factors for AKI and the potential of improving their management and 
outcomes. Unfortunately, these are not widely known and are variably 
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practiced worldwide, resulting in lost opportunities to improve the care 
and outcomes of patients with AKI. Importantly, there is no unifying 
approach to the diagnosis and care of these patients. 
There is a worldwide need to recognize, detect, and intervene to 
circumvent the need for dialysis and to improve outcomes of AKI. This 
agency was created to provide objective, science-based information to 
improve decision making in health-care delivery. 
Acute kidney injury (AKI), formerly called acute renal failure, is a 
clinical syndrome in which a sudden deterioration in renal function 
results in the inability of the kidneys to maintain fluid and electrolyte 
homeostasis. 
In the year 2000, the Acute Dialysis Quality Initiative (ADQI) 
proposed the RIFLE criteria for defining AKI. 
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CRITERIA ESTIMATED CCL URINE OUTPUT 
Risk eCCl decrease by 25% <0.5 mL/kg/hr for 8 hr 
Injury eCCl decrease by 50% <0.5 mL/kg/hr for 16 hr 
 
Failure 
eCCl decrease by 75% or 
eCCl<35 mL/min/1.73 m2 
<0.3 mL/kg/hr for 24 hr 
or anuria for 12 hr 
Loss Persistent failure >4 wk  
End-stage End-stage renal disease 
(persistent failure >3 month) 
 
 
EPIDEMIOLOGY 
The precise incidence of AKI in children is not well known. 
Prospective studies from our country suggest that 4-6% of paediatric 
inpatients in general wards, and up to 40% in PICUs show AKI and that 
renal failure is important in determining morbidity and mortality.  
AKI is frequent in the PICU, affects children who have sepsis and 
multi organ failure and is independently associated with high mortality. 
In the developing world, AKI is a disease of the young and secondary to 
single illnesses (gastroenteritis with dehydration, malaria, leptospirosis, 
hemolytic uremic syndrome, sepsis, red cell enzyme deficiencies). 
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ETIOLOGY 
Conditions that cause AKI can be classified into pre renal, intrinsic 
renal and post renal groups. 
Pre renal AKI results from inadequate renal blood flow due to 
hypovolemia. 
 If treated early with restoration of blood volume, it responds 
promptly with resumption of normal urine output and resolution of 
azotemia. 
Post renal AKI is due to obstruction in the urinary collecting 
system and there is absence of renal parenchymal disease.  
It is potentially reversible when the urinary tract obstruction is 
alleviated. 
 Both pre- and post renal conditions can, if prolonged can lead to 
renal parenchymal injury. 
Intrinsic renal disease: Hemolytic uremic syndrome (HUS), Acute 
tubular necrosis (ATN), Glomerulonephritis (GN) and Acute Interstitial 
Nephritis are important causes of AKI in children. 
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Causes of acute kidney injury 
Pre renal 
Acute gastroenteritis, blood loss, shock, fulminant hepatitis, Reye 
syndrome, Congestive heart failure, Nephrotic syndrome, Hepatorenal 
syndrome. 
Renal 
Major Vessel Obstruction 
 Renal vein thrombosis, renal arterial obstruction, 
 Hemolytic uremic syndrome,  
 Henoch-Schönleinpurpura, polyarteritis and other vasculitis. 
Glomerular 
 Acute glomerulonephritis  (poststreptococcal, other infections),  
crescentric GN 
Acute Tubulointerstitial Nephritis 
Acute Tubular Necrosis 
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Prolongation of prerenal insult, intravascular hemolysis, sepsis, 
nephrotoxic agents, multi organ failure, rhabdomyolysis, snakebite, other 
envenomations, falciparum malaria , leptospirosis 
Post renal 
Obstructive uropathy  (calculi, blood clots), neurogenic  bladder. 
Pathogenesis of Acute Tubular Necrosis 
Sustained and severe hypoperfusion leads to endothelial and 
tubular epithelial cell damage. 
Obstruction of the tubules by cell debris and back leak of the 
glomerular filtrate across the damaged tubular epithelium result in 
oligoanuria. 
The straight portion of proximal tubule (S3 segment) is most 
susceptible to ischemic and toxic injury, followed by S1 and S2 segments 
and medullary ascending limb of Henle.  
Hemodynamic abnormalities during ischemia affect regional blood 
flow and oxygen supply to the outer medulla of the kidney. 
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Acute tubular necrosis, Extensive tubular damage with loss of 
brush border and tubular cells, Regenerating tubular cells. 
Specific Etiologies 
Important causes of AKI are discussed below. 
Nephrotoxic Agents 
Because of its large blood flow and capacity to concentrate the urine, the 
kidney is exposed to high concentrations of toxic substances. These may 
be exogenous or endogenous. Renal failure is characteristically non 
oliguric and associated with tubular dysfunction 
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Aminoglycosides:  
Clinically significant toxicity may occur in 10 percent patients and 
in up to 70 percent of certain high risk groups. Factors influencing 
toxicity include age of the patient, dose and duration of treatment, 
hydration status, pre-existing renal disease, renal ischemia, hypokalemia, 
hypomagnesemia, acidosis and renal or hepatic insufficiency.  
Aminoglycosides are minimally protein bound and not 
metabolized. After glomerular filtration they are bound to phospholipids 
in the proximal tubular membrane and internalized. They inhibit protein 
synthesis, mitochondrial respiration and membrane enzyme activity. 
Loop diuretics promote tubular cell uptake of aminoglycosides and 
increase their toxicity. Patients with pre-existing renal ischemia have 30 
to 40 percent greater chance of toxicity. Mild proteinuria, lysozymuria, 
defective concentrating ability and polyuria precede a decline in 
glomerular filtration. Aminoglycosides are less toxic in neonates despite 
higher blood levels since reduced cortical blood flow results in lower 
cortical accumulation of these drugs. 
Amphotericin:  
The drug complexes with cell membrane sterols causing oxidative 
damage and lipid peroxidation. Since it alters macula densa permeability 
 
 
12 
 
it increases tubuloglomerular feedback and afferent arteriolar 
vasoconstriction. It also acts on principal cells of the collecting ducts 
creating more sodium channels, and increasing sodium reabsorption and 
potassium secretion. Deoxycholate, a solubilizing agent in preparation of 
amphotericin, is also nephrotoxic. Some degree of nephrotoxicity is 
predictable during treatment, but severe renal injury is rare. The clinical 
problems associated with amphotericin B administration include 
potassium and magnesium wasting, mild distal renal tubular acidosis and 
loss of concentrating capacity with polyuria. Treatment consists of saline 
loading and hydration. The dosage can be reduced or an alternate day 
regimen instituted. Rarely large doses may induce renal insufficiency. 
The liposomal preparation of amphotericin B is less nephrotoxic is now 
being preferred. Persistent hypomagnesemia may result, which is 
corrected by administration of magnesium hydroxide or gluconate (1-2 
mEq/kg daily). Renal failure may be prolonged. 
Ifosphamide: 
 Ifosphamide increases tubular loss of glucose, calcium, phosphate 
and magnesium. The toxicity may result in hypophosphatemic rickets, 
nephrogenic diabetes insipidus, renal tubular acidosis and rarely Fanconi 
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syndrome. This drug is more toxic in children below 3 years especially 
with large doses. 
Radio contrast media:  
These agents may cause direct tubular cell injury, tubular luminal 
obstruction and renal hemodynamic abnormalities. The incidence of 
radiocontrast nephropathy is between 10-15%. Patients with dehydration, 
pre-existing renal disease and recent nephrotoxin exposure are 
particularly at risk. Use of isoosmolar (290 mOsm/kg) contrast agents at 
the minimum volume, maintenance of adequate hydration (saline or 
bicarbonate based IV fluids at the rate of 1.0 ml/kg/min for 3–12 hours 
before and 6-12 hours after contrast exposure) and oral administration of 
the antioxidant, N-acetylcysteine (600-1200 mg twice daily for 2 days) is 
useful in reducing the risk of contrast nephropathy. 
Prolonged anaesthetic use of methoxyflurane may cause increased 
excretion of urinary oxalate, formation of calcium oxalate crystals and 
nonoliguric AKI. 
Other agents, reported to cause AKI in children include ibuprofen, 
ketorolac, acyclovir, ACE inhibitors, cyclosporin A and intravenous 
immunoglobulin. 
 
 
14 
 
Outbreaks of severe systemic toxicity and AKI from diethylene glycol 
contaminated glycerin, used to manufacture acetaminophen, have been 
reported from Bangladesh, Haiti and India. The outcome of toxin-
mediated AKI is usually good, if the offending agent is promptly 
recognized and discontinued and adequate treatment of AKI instituted. 
Snakebite 
Snakebites are more serious in children because of the relatively 
large volume of venom injected. A bite by viper produces hemorrhagic 
manifestations such as epistaxis, hemoptysis, hemetemesis, hematuria, 
hypotension and shock. AKI may develop due to intravascular hemolysis, 
shock and direct tubular injury. 
Prompt administration of specific antivenom markedly reduces the 
severity of the manifestations. 
 Intravascular Hemolysis 
Patients with G6PD deficiency, after exposure to a variety of 
drugs, most notably antimalarials (such as primaquine), sulfonamides, 
nitrofurantoin and naphthoquinones, and occasionally infections may 
develop acute intravascular hemolysis. The extent of hemolysis depends 
upon the amount of drug taken and the degree of enzyme deficiency. In 
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severe cases there is rapid onset of pallor, mild jaundice and 
hemoglobinuria. Renal tubular damage is indicated by high blood urea 
and creatinine. AKI may develop (being usually nonoliguric) if prompt 
management (blood transfusion and maintenance of a high urine flow 
rate) is delayed. Alkalization of the urine is recommended. 
Malaria 
AKI is an important complication of severe P. falciparum 
infection, though it can rarely occur with vivax malaria. Falciparum 
malaria is common in northeastern regions, and is also observed in 
Rajasthan. P. falciparum infection can lead to a wide spectrum of renal 
involvement. The parasite invades red cells of all ages and in severe cases 
there is a very high degree of parasitemia, which compromises the 
microcirculation. Inflammation plays a major role in renal injury through 
release of tumor necrosis factor- and interleukin-1, which upregulate 
expression of adhesion molecules. Blood flow is impaired due to 
hyperviscosity induced by rigid parasitized red cells and increase in acute 
phase proteins in plasma. In severe cases increased capillary permeability 
may lead to hypovolemia, and reduction in renal blood flow and GFR. 
Immunologic mechanisms may cause mesangial proliferative GN with 
deposition of IgM and C3. 
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Urine examination shows mild proteinuria, microscopic hematuria 
and granular casts. Biochemical abnormalities include hyponatremia 
(resulting from ADH stimulation, intracellular sodium inflow and urinary 
sodium loss), hypokalemia and respiratory alkalosis. With development 
of AKI, there is hyperkalemia, which is also contributed to by 
intravascular hemolysis and rhabdomyolysis. AKI is ischemic in origin 
and usually hypercatabolic, with ATN as the characteristic feature. 
Intensive supportive care and dialysis lead to full recovery in most cases, 
unless complications such as shock and multiorgan failure develop. 
Leptospirosis 
Leptospirosis is an important cause of AKI in many countries, 
including coastal regions of south India. Infection occurs when abraded 
skin and mucous membranes come in contact with urine of infected rats 
or other animals or contaminated water or soil. Clinical features include 
severe myalgia, chills, fever and conjunctival injection. Liver, lungs and 
gastrointestinal tract are usually affected. Renal involvement is 
manifested by hematuria and proteinuria. ATN may occur in severe cases. 
Optimal supportive care and dialysis lead to complete recovery. 
Preventive measures consist of hygienic precautions and use of 
appropriate footwear. 
 
 
17 
 
Sepsis 
Sepsis is the most common cause of AKI in PICU. Patients with 
sepsis and AKI present complex and difficult problems and usually have 
a poor prognosis.  
Endotoxemia stimulates the induction of NO synthase, which leads 
to nitric oxidemediated arterial vasodilatation. The resultant arterial under 
filling causes an increase in sympathetic activity, nonosmotic release of 
arginine vasopressin and activation of renin-angiotensin-aldosterone 
system. These lead to renal vasoconstriction with retention of sodium and 
water and increase in cardiac output, which maintain arterial circulation, 
but may lead to ATN. Sepsis and endotoxemia with AKI lead to early 
noncardiogenic pulmonary edema, hypoxia and the need for mechanical 
ventilation. With prolonged ventilatory support, adult respiratory distress 
syndrome, and multiple organ dysfunction develop and are responsible 
for the very high mortality. Sepsis affects the expression of complement, 
coagulation and the fibrinolytic cascade and may lead to disseminated 
intravascular coagulation. 
Early vasoconstrictor phase of sepsis and AKI should be 
potentially reversible. 
 
 
18 
 
Prompt volume expansion with isotonic fluids and appropriate 
administration of vasopressors (i.e. dopamine, catecholamines, 
vasopressin) to maintain mean blood pressure of 65 mm Hg or more, 
central venous pressure of 8-12 cm, venous saturation >80% and urine 
output >0.5 ml/kg/h is recommended to prevent the occurrence of AKI 
and improve outcomes. Hyperglycemia impairs the function of 
leukocytes and macrophages, and insulin may be used to maintain the 
blood glucose at around 145 mg/dl. Patients with sepsis and AKI are 
hypercatabolic.  
Intensive dialysis support and continuous hemofiltration improve 
survival. 
Crush Injuries 
AKI is a common and serious complication of crush injuries that 
frequently occur following collapse of multi-storeyed buildings and 
earthquakes. Subjects are trapped underneath falling beams and debris, 
often for prolonged periods. Extensive injury to muscles with liberation 
of myoglobin, hypovolemic shock due to sequestration of large amounts 
of fluids in damaged muscles and lack of fluid intake lead to AKI. Injury 
to sarcolemmal membrane causes movement of water, Na+ and Ca2+ into 
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the cells and that of K+, proteins, phosphate, lactate, myoglobin, 
thromboplastin and creatine kinase in the reverse direction. 
Hyperkalemia, hypocalcemia, hyperphosphatemia and lactic 
acidosis are important. Urine is brown-colored from heme pigment. 
Immediate management includes volume replacement to correct 
hypovolemia and shock, if possible before releasing the beams and 
debris, since renal injury takes place during reperfusion. Along with the 
infusion of 0.9 percent saline and 2.5 percent glucose, IV insulin with 5 
percent glucose and 1 ml/kg of 10 percent calcium gluconate are 
administered to correct presumed hyperkalemia and hypocalcemia. An 
alkaline urine pH (>6.5) prevents cast and methemoglobin formation. 
Detailed clinical and laboratory examination is carried out to evaluate the 
severity and complication of AKI and look for injury to other organs. 
The initial resuscitative measures should lead to rise in systolic 
blood pressure, fall in heart rate, warming of hands and feet and improved 
sensorium. If severe oliguria persists after restoration of circulation, 5 
ml/kg of mannitol and 2 mg/kg of frusemide are administered. If that fails 
to induce diuresis, intrinsic renal AKI is presumed, and hemodialysis 
instituted (peritoneal dialysis usually is insufficient in crush syndrome). 
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In the absence of prompt and adequate management, the prognosis is 
poor. 
Rhabdomyolysis 
Besides extensive muscle injury, severe rhabdomyolysis and 
myoglobinuria may occur following a variety of infections including 
Coxsackie virus, viral hepatitis, leptospirosis and influenza. Myoglobin 
and hemoglobin increase renal vasoconstriction by inhibiting production 
of endothelial NO. Volume depletion also contributes to the occurrence 
of AKI. There is a rapid rise in levels of blood urea, creatinine and 
phosphate. The urine is dark brown and does not contain red blood cells. 
Adequate hydration along with use of frusemide and urinary alkalization 
may prevent or attenuate tubular injury. 
 Tumor Lysis Syndrome 
AKI may develop in children with malignant conditions such as 
leukaemia and lymphoma. Several factors may be contributory including 
nephrotoxicity of chemotherapeutic agents, massive infiltration of renal 
parenchyma by malignant cells and rapid tumor lysis (tumor lysis 
syndrome). A rapid release of uric acid and high levels lead to 
precipitation of uric acid crystals in tubular lumen and renal 
microvasculature are important in the development of AKI.  
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Prophylactic treatment with allopurinol inhibits uric acid synthesis 
but causes increase of its precursors, xanthine and hypoxanthine that are 
highly insoluble and get precipitated. Rasburicase, an analogue of urate 
oxidase, converts uric acid to allantoin, which is much more soluble than 
uric acid. 
Very high levels of phosphates may develop and cause 
precipitation of calcium phosphate crystals. Adequate hydration and 
alkalization of urine to pH 7.5-8.0 should be maintained during 
chemotherapy. Hemodialysis should be instituted if there is 
hyperuricemia or severe hyperphosphatemia with oliguria. 
Hepatorenal Syndrome 
This is a form of volume unresponsive, refractory pre renal 
azotemia in patients with chronic liver disease, characterized by systemic 
and splanchnic vasodilatation, but profound renal vasoconstriction 
without parenchymal kidney injury. Several liver diseases (cirrhosis, 
fulminant hepatitis and Reye syndrome) may lead to profound renal 
hypoperfusion and AKI. Ascites and hypoalbuminemia are usually 
present. Paracentesis, bleeding or infection may precipitate ARF. 
Urinalysis shows features of pre renal ARF (Na+ <10 mEq/l, osmolality 
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>450 mOsm/kg, protein <200 mg/m2 and rarely red blood cells), 
excluding significant glomerular or tubulointerstitial disease. 
The prognosis is poor, because of seriousness of the underlying 
hepatic disease. Meticulous attention to fluid and electrolyte therapy, 
prevention of secondary infections and renal replacement therapy might 
be necessary. A combination of albumin and terlipressin (V1-selective 
vasopressin analog) has been shown to improve clinical outcomes. Other 
splanchnic vasoconstrictors that are effective include norepinephrine and 
octreotide. Without orthoptic liver transplantation, the mortality may be 
as high as 70 to 90 percent. 
Multi organ Failure 
In intensive care units, AKI is frequently observed in children with 
sepsis and multi organ failure. Systemic inflammatory response may 
contribute to AKI and dysfunction of other organs. Extensive patho 
physiological derangements have been observed, including increased 
production of cytokines and reactive oxygen molecules, activation of 
polymorphonuclear leukocytes and upregulated expression of leukocyte 
adhesion molecules. Hemodynamic instability is usually present and 
CRRT is appropriate in the management of these patients. 
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Diet 
Patients with AKI have increased metabolic needs and are usually 
catabolic. 
Adequate nutritional support is desirable with maximization of 
caloric intake. 
The volume restriction necessary during the oliguric phase often 
imposes limits on the caloric intake. A diet containing 1.2 to 2 g/kg of 
protein in infants and 0.8 to 1.2 g/kg in older children, and a minimum of 
60 cal/kg should be given. 
The latter requirement can be met by adding liberal amounts of 
carbohydrates and fats to the diet. Once dialysis is initiated, dietary 
protein, fluid and electrolyte intake should be increased. Supplements of 
vitamins (thiamine, riboflavin, pyridoxine, folic acid, cynacobalamin, 
ascorbic acid) and micronutrients should be provided. If oral intake is 
inadequate, parenteral alimentation may be considered. 
Management of Infections 
Patients with AKI are more susceptible to develop infections 
because of depressed immune system induced by azotemia and 
concomitant malnutrition, and invasive procedures. Various infections 
 
 
24 
 
(respiratory and urinary tract, peritonitis and septicemia) are the 
immediate cause of death in majority of patients. All procedures should 
be performed with aseptic techniques, intravenous lines carefully 
watched, and skin puncture sites cleaned and dressed. Oral hygiene 
should be ensured. Devitalized tissue and collections of blood should be 
removed. 
Long-term catheterization of the bladder should be avoided. 
Sepsis is suggested by hypothermia, persistent hypotension, 
hyperkalemia and a disproportionate rise of blood urea compared to 
creatinine. The patient should be frequently examined to detect infection, 
which may be present without fever. 
If infection is suspected, appropriate specimens are taken for 
culture and antibiotics started. 
Use of Medications 
Drugs that increase severity of renal damage or delay recovery of 
renal function should be avoided. Important drugs in this category include 
aminoglycosides, radiocontrast media, NSAIDs and amphotericin B. 
Those that reduce renal perfusion, e.g. ACE inhibitors and indomethacin 
are not recommended in patients with renovascular disease or following 
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renal transplantation. The dose and dosing interval of antibiotics should 
be modified depending on the severity of renal injury. 
There is no evidence that diuretics improve either renal function or 
the prognosis of intrinsic renal failure. Diuretics may improve urine 
output but not the glomerular filtration rate. They may be useful in 
instances where a high urine flow is required to prevent intratubular 
precipitation as with intravascular hemolysis, hyperuricemia and 
myoglobinuria. Frusemide can cause ototoxicity, interstitial nephritis, 
hypotension or persistence of patent ductus arteriosus in the newborn. 
Agents that Attenuate Injury or Hasten Recovery 
Dopamine at low doses causes renal vasodilatation and may induce 
a modest natriuresis and diuresis. All recent studies have consistently 
failed to show a beneficial effect of dopamine infusion on the outcome of 
AKI, and its routine use for prevention or treatment of ATN is not 
recommended. Infusion of dopamine might be associated with transient 
tachycardia, arrhythmias, and myocardial and tissue ischemia. 
Fenoldopam (0.03-0.1  g/kg/min), a selective peripheral dopamine 
receptors agonist, has shown promise in preventing AKI in patients 
undergoing cardiac surgery. Treatment with low dose atrial natriuretic 
factor, especially in postoperative patients, has shown beneficial effects 
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in randomized controlled studies. Calcium channel blockers, antioxidants, 
thyroxin, peptide growth factors and cytokines been used anecdotally to 
attenuate renal injury or enhance recovery of renal function. At present, 
none of these agents has a place in the management of AKI. Further 
trials, especially in children, are necessary. 
Monitoring 
The child with AKI should be closely monitored. Accurate record 
of intake and output and weight should be maintained. Laboratory tests 
are done depending upon the stability of the patient’s condition, 
progression of AKI and presence of complications. Careful physical 
examination should be done at least twice a day or more frequently if 
necessary. 
Biochemical Derangement with Persistent AKI 
Hyponatremia 
Serum sodium level below 130 mEq/l may be present initially in 
AKI or develop later during the course of management. In both instances, 
hyponatremia usually is the result of excessive fluid administration rather 
than sodium loss. Profound hyponatremia when associated with sensorial 
alteration or seizures requires prompt correction. Serum sodium 
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concentration should be increased by 5 to 10 mEq/l over 30 to 90 minutes 
by infusion of 3 percent saline; 12 ml/kg of this solution will raise serum 
sodium by 10 mEq/l. 
It must be emphasized that sodium administration is usually not 
required to correct the hyponatremia associated with AKI. Fluid 
restriction is the primary mode of therapy. Sodium administration is 
hazardous in a patient with excessive body water and may cause 
hypertension and congestive cardiac failure. 
Hyperkalemia 
Serum potassium levels should be measured every 12 to 24 hr and 
ECG obtained as necessary. Hypercatabolic states and extensive tissue 
breakdown lead to increase in blood potassium levels. Potassium rich 
foods should be avoided and hyperkalemia controlled by administration 
of potassium exchange resins. Sodium polystyrene sulfonate (Kayexalate) 
is administered as freshly prepared suspension in water or syrup (1 g resin 
in 3-4 ml) orally (through a stomach tube if necessary) or by enema. One 
gram resin/kg body weight reduces serum potassium by 1 mEq/l. If the 
resin induces constipation, sorbitol (or lactulose) may be used. 
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The side effects include anorexia, nausea, hypokalemia and sodium 
retention. 
Calcium exchange resin is also available and may be preferred. 
Dialysis is often required if hyperkalemia develops in patients with 
oligoanuria. 
Hyperphosphatemia, Hypermagnesemia and Hypocalcemia 
Once ARF has persisted for few days, hyperphosphatemia (6-8 
mg/dl) and hypermagnesemia may develop, because of retention of these 
ions. The former is aggravated if a hypercatabolic state or 
rhabdomyolysis is present. 
Hypocalcemia also usually occurs but is mostly asymptomatic 
because of associated acidosis. Tetany or convulsions may be precipitated 
by excessive alkali therapy. Therefore calcium should be administered 
before correcting acidosis. 
Calcium gluconate or carbonate is administered at a dose of 30 to 
50 mg/kg elemental calcium. A diet containing low phosphate is given. If 
serum phosphate levels are above 7 mg/dl, short-term administration of 
aluminum hydroxide that chelates dietary phosphate may be useful. 
Severe hyperphosphatemia carries a risk of metastatic deposition of 
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calcium phosphate when the product of calcium and serum phosphate 
levels (mg/dl) exceeds 70. Dialysis is required if dietary modification and 
phosphate binders fail to reduce levels of serum phosphate. 
Hyperuricemia 
Hyperuricemia is common in AKI. If levels are below 15 mg/dl, no 
treatment is required. 
Diuretic Phase in AKI 
The clinical course of uncomplicated AKI (acute tubular necrosis) 
is often characterized by 3 phases: oligoanuria, diuresis and recovery. The 
first is obviously absent in nonoliguric AKI. The duration of oliguria may 
be a few hours to several weeks, but in uncomplicated ATN it usually 
lasts for 5 to 10 days. During the diuretic phase there is a progressive rise 
in urine output which may reach 2 to 3 L per day. Such high output is 
often due to excessive replacement of fluids and overhydration. A 
profound diuresis may be seen following relief of obstruction in postrenal 
AKI. 
During the diuretic phase the levels of blood urea and creatinine 
continue to increase and decline only after several days. The urine has 
low concentrations of urea and creatinine and contains large amounts of 
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electrolytes. Complications such as infections, gastrointestinal bleeding, 
convulsions and electrolyte abnormalities (e.g. hypokalemia) are frequent 
during the diuretic phase. The diuretic phase should be managed by 
replacement of urinary output with 0.45 percent saline and potassium if 
necessary. 
In uncomplicated AKI oligoanuria may last for 7 to 10 days at the 
end of which the urine output may start and progressively increase. Such 
patients may require only a single dialysis. If AKI is prolonged beyond 2 
to 3 weeks multiple dialyses may be required. In these cases, maintenance 
of nutrition and prevention of infections become crucial as most patients 
die of infection and inanition before significant recovery of renal 
function. 
OUTCOME 
Optimal management and dialysis can reverse the derangements 
caused by AKI. 
Despite advances in dialysis techniques, morbidity and mortality 
continue to remain high. Mortality rates of 30 to 50 percent have been 
reported from developing countries, but the results have markedly 
improved at tertiary centres with proper expertise and modern facilities. 
The outcome chiefly depends upon the underlying condition. The 
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prognosis is favourable in ATN from volume depletion, intravascular 
hemolysis, milder forms of diarrhoea-related HUS, acute interstitial 
nephritis, and drugs or toxins related AKI, especially when complicating 
factors are absent. In crescentic GN, atypical HUS, and AKI associated 
with sepsis, multiple organ failure and following major cardiac surgery, 
the prognosis is less satisfactory. The patients are often referred late to 
tertiary centers by which time serious complications are already present. 
Long-term Outcome 
Although complete recovery usually occurs in uncomplicated AKI 
with renal function becoming normal, many patients have a significant 
risk of developing chronic renal damage. That especially applies to 
patients with seemingly mild D+ (typical) HUS, and AKI secondary to 
medications and toxins, and perinatal hypoxia. Patients with AKI should 
be observed for several years with regular monitoring of blood pressure, 
urinalysis and estimation of blood levels of creatinine. 
PREVENTION OF ACUTE KIDNEY INJURY 
Several conditions that cause AKI can be prevented. Important 
measures include prompt rehydration therapy in acute diarrhea, avoidance 
or judicious use of nephrotoxic drugs, careful observation of patients 
receiving antimalarial drugs and maintenance of proper hydration for 
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patients undergoing diagnostic procedures with radiocontrast media. 
Forced diuresis along with the use of allopurinol is effective in preventing 
AKI in patients with tumor lysis syndrome. 
Krishnamurthy, 2016 et al in 2016 conducted a retrospective study 
on the clinic  etiological profile of AKI in 227 PICU patients and 
concluded that 6% developed AKI ;of these 51.6% had risk,35.4% had 
Injury of 12.9%`had Failure & overall mortality was 32.3%.Hypoxia was 
found to be the major risk factor for AKI followed by nephrotoxic drugs 
and hypotension. sepsis was the most common etiology. 
Maqbool et al in 2018 conducted a prospective observational study 
on Incidence and etiology of acute kidney injury in children admitted to 
picu using pRIFLE criteria in 500 PICU patients & concluded that 31% 
developed AKI. Of these 93 % had risk,  46 % had injury, 15 % had 
failure. Hypotension, Nephrotoxic drugs, Sepsis and need for mechanical 
ventilation were significant (P<0.001) risk factors for AKI. They 
concluded that Infections are leading etiology of AKI in children. p 
RIFLE staging system provides early identification and stratification of 
AKI. 
Panwar et al in 2016 conducted a prospective study on the 
epidemiological profile, clinic biochemical spectrum and prognosis of 
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malaria induced renal dysfunction in paediatric age group in 200 picu 
cases& concluded that 30 % had malaria induced acute kidney injury. 
The spectrum of renal involvement of malaria is variable ranging from 
mild stage of renal derangement to advanced stage of renal dysfunction 
which needs immediate dialysis. Severe involvement was seen in mainly 
Pvivax infection 
Shyna et al in 2009 conducted a descriptive cross sectional study 
on clinical profile of poisonous snake bite in children of north kerala, in 
50 cases of snake bite & concluded that highest number of bite in the age 
group 11-15 years.6 % developed AKI, of these50% had risk,13% had 
injury,2% had failure. Viper bite accounted for the highest number 
followed by krait, cobra.  
GOPAL BASU  et AL conducted a study 
Methods: Consecutive adult inpatients of a tertiary hospital in 
southern India with tropical acute febrile illness between January 2007 
and January 2008 were prospectively studied for the incidence and 
severity of AKI based on RIFLE classification and its association with 
mortality and dialysis requirement. 
          Results: The 367 patients (mean age 39.7 ± 16.9 years; 60% 
males) with tropical acute febrile illness due to scrub typhus (51.2%), 
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falciparum malaria (10.4%), enteric fever (8.7%), dengue (7.6%), mixed 
malaria (6.5%), leptospirosis (3.3%), undifferentiated acute febrile illness 
(8.4%) and others (3.8%) (spotted fever, vivax malaria and Hantaan virus 
infection) had an overall mortality rate of 12.3%. 
 The incidence of AKI was 41.1%; of which, 17.4%, 9.3% and 
14.4% were in the Risk, Injury and Failure classes, respectively. Of the 
patients, 7.9% required dialysis. Among the Risk, Injury and Failure 
groups, there was an incremental risk of mortality. 
Nair JJ et al conducted a study on consecutive 600 adult tropical 
acute febrile illness patient in tertiary care centre in costal Karnataka. 
 On the spectrum and staging of acute kidney injury ,renal 
replacement therapy ,and In hospital mortality , 
 They reported that proportion of AKI 
- Following malaria was 51 % &AKI stage 2,3 
- following leptospirosis, stage 1 
- followed by dengue fever, 
- vivax malaria  third most common cause of AKI  
 Conroy et al conducted a study on 180 children between 1-10 years 
with severe malaria in Uganda on how  common AKI was in 
paediatrics  malaria, 
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 They reported that 45.5% of children  with severe malaria had 
acute kidney injury   
 ANACLETO et al conducted a study on 86 children < 18 year old 
who presented with clinical manifestation of leptospirosis and 
microscopic agglutination test >1:400, in tertiary care centre on 
Phillippiness.  
 The clinical  profile of acute kidney injury in paediatric 
leptospirosis showed  that out of 86 children, 53  were 
oliguric/anicteric  AKI due to leptospirosis was more frequent/ 
severe than non oliguric kidney failure in paediatric population. 
Ashish Jacob Mathew et al reported that natural medicine used by 
traditional healers add to the burden of AKI in tropical countries. 
Endemic malnutrition, relative hypovolemia, due to increased 
sweating and peripheral vasodilatation due to hot climate were other 
notable features. 
Incidence of AKI in severe leptospirosis was found to range from 
40% to 60 % 
AKI was found to be non oliguric in leptospirosis and associated 
with hypokalemia 
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Emmanuel A.Burdmann et al reported malaria, yellow fever, 
dengue, leptospirosis as the common causes of AKI in the tropics 
Rashad.S.Baroum et al opined that genetic, socioeconomic and 
environmental factors interact in increasing the morbidity from AKI 
caused by tropical infections 
 Elizabeth et al reported visceral leishmaniasis as a significant cause 
of AKI in the tropics 
Biomarkers for Early Diagnosis 
In most cases of AKI severe impairment of renal function is 
present and only supportive management is possible until recovery takes 
place, especially if recognition of AKI is delayed. 
However, if AKI can be anticipated or incipient AKI is detected 
early, preventive strategies could be instituted.  
A high index of suspicion of AKI is warranted in children 
undergoing major surgery or organ transplantation those with multiorgan 
failure and neonates with hypoxia and sepsis. 
Attempts have been made to identify biomarkers, which would 
indicate renal injury before a rise in serum creatinine.  
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The most promising of these include Neutrophil Gelatinase 
associated lipocalcin (NGAL), Interleukin-18 (IL-18), kidney Injury 
Molecule-1 (KIM-1) and cystatin C.  
High urine NGAL levels have been detected very early in children. 
Who have undergone, major surgery who subsequently developed AKI 
and several other clinical situations complicated by AKI. 
IL-18, a pro inflammatory cytokine, is detected in the urine in 
ischemic AKI. It is likely that easily measurable methods of these 
biomarkers would become available in future which may help in the 
management of patients. 
Optimization of intravascular volume and renal perfusion with 
particular attention to medications being used as well as close monitoring 
of patients would  help to prevent and promptly manage AKI. 
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CLINICAL MANIFESTATIONS AND DIAGNOSIS 
A carefully taken history is critical in defining the cause of AKI. 
An infant with a 3 day history of vomiting and diarrhoea most likely has 
pre renal AKI caused by volume depletion, but hemolytic-uremic 
syndrome (HUS) must be a consideration.  
A 6 yr old child with a recent pharyngitis who presents with periorbital 
edema, hypertension, and gross hematuria most likely has intrinsic AKI 
related to acute post infectious glomerulonephritis. 
A critically ill child with a history of protracted hypotension or 
with exposure to nephrotoxic medications most likely has ATN. 
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A neonate with a history of hydronephrosis on prenatal ultrasound 
and a palpable bladder most likely has congenital urinary tract 
obstruction, probably related to posterior urethral valves. 
 
The physical examination must be thorough, with careful attention to 
volume status. Tachycardia, dry mucous membranes, and poor peripheral 
perfusion suggest an inadequate circulating volume and the possibility of 
pre renal AKI . Hypertension, peripheral edema, rales, and a cardiac 
gallop suggest volume overload and the possibility of intrinsic AKI from 
glomerulonephritis or ATN. The presence of a rash and arthritis might 
indicate systemic lupus erythematosus (SLE) or Henoch-
Schönleinpurpura nephritis. Palpable flank masses may be seen with renal 
vein thrombosis, tumors, cystic disease, or urinary tract obstruction. 
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LABORATORY FINDINGS 
Laboratory findings include 
a) Anaemia 
  due to SLE(Dilutional or Hemolysis) 
           Renal vein thrombosis 
    b)  Leucopenia 
  due to SLE                     
           Sepsis 
b) Thrombocytopenia 
  due to SLE 
                     Renal vein thrombosis 
                     Sepsis  
   d) Hyponatremia 
   e) Metabolic acidosis 
   f) Hypocalcemia (due to Hyperphosphatemia ) 
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Urinary indices 
 Pre renal Renal failure Intrinsic Renal Failure 
Urine osmolality  500 mosm/kg <350 mosm/kg 
FENA <    1 %  2% 
Urine sodium < 10  20 
Urine specific gravity  1.020 < 1.010 
 
CHEST XRAY FINDINGS: 
 Cardiomegaly 
 Pulmonary congestion 
 Pleural Effusion  
Antibodies may be diluted in serum to 
a) Streptococcal in Post Streptococcal Glomerulonephritis 
b) Nuclear in SLE 
c) Neutrophilic cytoplasmic in microscopic polyangiitis. 
URINANALYSIS: 
The presence of Hematuria, proteinuria and RBCs or granular 
urinary casts suggest intrinsic AKI (Glomerular disease and Acute 
Tubular Necrosis). 
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The presence of White blood cells and white blood cell casts with 
low grade Hematuria and Proteinuria suggest tubulointerstitial disease. 
Urinary eosinophils may be present in children with drug induced 
tubulointerstitial nephritis. 
TREATMENT:  
For pre renal AKI ,  by fluid replacement and maintaining adequate 
perfusion we can prevent it. 
In AKI, Hyperkalemia more common, when potassium level 
exceeds more than 7mEq/l along with echocardiographic changes, 
Calcium Gluconate 10% solution 1ml/kgIV over 10-15 mins 
Sodium bicarbonate1-2mEq/kg IV over 5-10 mins 
Regular insulin 0.1 units/kg with 50% glucose solution, 1mg/kg 
over 1 hr. 
Hypocalcemia can be treated by lowering the serum phosphate by 
using phosphate binders  
Hyponatremia can be corrected by fluid restriction. When 
hyponatremia associated with seizures, lethargy or serum sodium level, 
120mEq/l, Hypertonic saline can be given. 
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  Hypertension can be controlled with calcium channel blockers like 
amlodipine (or) beta blockers [Labetalol] 
DIALYSIS 
  
 Indication for dialysis 
 Anuria or oliguria 
 Volume overload 
 Persistent hyperkalemia 
 Severe metabolic acidosis  
 Uremia>100-150mg/dl 
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MODALITIES OF TREATMENT 
a) Intermittent hemodialysis 
b) Peritoneal dialysis 
c) Continuous replacement therapy 
TROPICAL DISEASES  
Scrub typhus, a rickettsial infection (Orientia tsutsugamushi), is 
transmitted by trombiculid chigger mites (especially Leptotrombidium 
deliense), found in semi-arid regions of heavy scrub vegetation. Its 
distribution was initially limited to a triangular area (the tsutsugamushi 
triangle) bordered by Japan, eastern Australia and eastern Russia, which 
includes India (sub-Himalayan and southern India), China and the Far 
East. This infection often presents with fever, maculopapular rash with an 
eschar at mite-bite site, myalgia, hepatosplenomegaly and, in severe 
cases, with acute lung injury, AKI, and multi-organ dysfunction. The case 
fatality rate ranges from 3% to 50%. It is diagnosed by a scrub typhus 
ELISA and treated with drugs such as doxycycline, chloramphenicol, 
ciprofloxacin and azithromycin. It is grossly under-reported and under-
diagnosed , due to lack of awareness, non-availability of the diagnostic 
test at peripheral centres and widespread use of empirical broad-spectrum 
antibiotics for acute febrile illnesses. 
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The disease was not limited to the people of the low socioeconomic 
status and was observed across the rural–urban divisions. There is a 
paucity of literature on the nature and aetiological factors in the evolution 
of AKI in this infection. The putative mechanisms include pre-renal 
failure, septic shock, rhabdomyolysis, direct renal invasion of 
O.tsutsugamushi , use of non-steroidal anti-inflammatory drugs 
(NSAIDs) and acute interstitial nephritis secondary to empirical use of 
antibiotics (e.g. ciprofloxacin). 
 AKI in malaria is due to renal ischaemia (microvascular plugging), 
tubular toxicity (haemolysis) and widespread inflammation secondary to 
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sepsis syndrome. Probably due to early diagnosis and effective treatment, 
the mortality is much lower (13.2% and 4.2%) compared with the other 
acute febrile illnesses. However, all patients who died had AKI, making it 
an important risk factor for mortality. 
Dengue, a day-biting mosquito-borne (Aedes aegypti) infection 
caused by various strains of Dengue flavivirus, AKI is predominantly due 
to reduced renal blood flow as in dengue shock syndrome, sepsis 
syndrome, rhabdomyolysis, empirical use of NSAIDs for analgesic–
antipyretic effects, and other rare causes. In keeping with the severity of 
the disease, this acute febrile illness had the highest mortality rate (25%), 
AKI being a significant risk factor.  
The incidence of leptospirosis in our study was lower than that 
observed in centres with humid, marshy environment and higher rainfall. 
AKI is predominantly a non-oliguric acute interstitial nephritis, often 
associated with hyponatraemia and hypokalaemia. The incidence of other 
acute febrile illnesses such as vivax malaria and spotted fevers was 
comparatively lower and had similar rates of AKI, RRT requirement, and 
mortality. 
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METHODOLOGY 
 
STUDY DESIGN            : Cohort Study  
STUDY PLACE              :  PICU Coimbatore Medical college 
Hospital, Coimbatore 
STUDY PERIOD            :  September 2016 to September 2017  
STUDY POPULATION:  Children aged between 1 month-12 years 
admitted for acute febrile illness 
satisfying    AKIN/RIFLE criteria for 
AKI  
 
The children are designated as AKI as per AKIN criteria  
 Absolute rise in serum creatinine more than 0.3 mg/dl from 
baseline and/or 
 Rise in serum creatinine more than 50% from baseline and/or 
 Fall in urine output to  less than 0.5ml/kg per/hour for more than  
6hours and/or 
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RIFLE CRITERIA 
 
 
SAMPLING TECHNIQUE: 
Purposive sampling/non probability sampling 
 
SAMPLE SIZE:   50 
SAMPLE SIZE FORMULA: 
 n= t2p(1-p ) 
m2 
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DESCRIPTION: 
n= required sample size 
t= confidence level of 95%(standard value of 1.96) 
p= expected frequency of the factor under study- 5% 
M= margin of error of 5% (standard value of 0.05)  
ࡺ =  ૚.ૢ૟૛࢞ ૙.૙૞ (૚ − ૙.૙૞)
૙.૙૞૛  
                                       = 50 
INCLUSION CRITERIA: 
All children aged between 1 month-12yrs with fever or with 
features of envenomation requiring hospitalization satisfying AKIN/p 
RIFLE criteria. 
EXCLUSION CRITERIA: 
Children with - Obstructive Uropathy 
  Post streptococcal  glomerulonephritis 
  IdiopathicNephrotic syndrome  
  Vesicoureteric reflux 
  Inborn error of metabolism  
  Diabetic Milletus 
  Congenital malformations of the kidney 
                                                     Chronic kidney disease & Malignancy 
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METHOD: 
 Samples for blood urea& serum creatinine drawn from all Children 
aged between 1 month-12 years admitted with acute febrile illness 
are tested at the time of admission and again at 48 hours after 
admission. 
 The children as designated as AKI as per pRIFILE/AKIN criteria 
are recruited for the study. 
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Or AKIN CRITERIA 
 Absolute rise in serum creatinine more than 0.3 mg/ dl from baseline 
 Rise in serum creatinine more than 50% from baseline 
 Fall in urine output to less than 0.5ml/kg per/hour for more than  6 
hours   
INVESTIGATIONS 
Fever workup: 
Complete blood count, Urine analysis, CRP, Blood culture, Urine culture, 
Peripheral smear study 
 Relevant confirmatory  Investigation  for concerned tropical 
disease :(as and when indicated) 
 Dengue serology 
 IgM Leptospirosis 
 IgM Scrub typhus 
 Hepatitis viral markers 
 Malaria card test 
 Blood culture(septicaemia) 
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IDSP GUIDELINEs 
S.No Disease Modified Case Definitions 
1 
Acute Diarrheal 
Disease 
(Including Acute 
Gastroenteritis) 
Passage of 3 or more loose watery stools in the past 24 
hours. (with or without vomiting) 
2 
Dysentery 
(*Old- Bacillary 
Dysentery) 
Acute diarrhoea with visible blood in the stool.(Source: 
Medical Officers’ Manual, IDSP, 2006) 
3 
Acute Hepatitis 
(* Old-Acute Viral 
Hepatitis) 
Acute illness typically including acute jaundice, dark 
urine, anorexia, malaise, extreme fatigue, and right 
upper quadrant tenderness. 
4 Enteric Fever 
Any patient with fever for more than one week and 
with any two of the following: 
  Toxic look 
  Coated tongue 
  Relative bradycardia 
  Splenomegaly 
   Exposure to confirmed case 
Clinical presentation with complications e.g. GI 
bleeding, perforation, etc. 
AND/OR 
Positive serodiagnosis (Widal Test) 
5 Malaria 
A case of fever which may be accompanied with any of 
the following (P). 
   Headache, backache, chills, rigors, sweating, 
myalgia, nausea and vomiting 
  Splenomegaly and anaemia 
   Generalized convulsions, coma, shock, spontaneous 
bleeding, pulmonary edema, renal failure and death. 
 
 
53 
 
6 Dengue Fever 
An acute febrile illness of 2-7 days duration with two or 
more of the following manifestations: 
 Headache, retro-orbital pain, 
 myalgia, 
 arthralgia, 
 rash, 
 haemorrhagic manifestations 
 leukopenia. 
Or 
Non-ELISA based NS1 antigen/IgM positive. 
(A positive test by RDT will be considered as probable 
due to poor sensitivity and specificity of 
currently available RDTs.) 
7 Chikungunya 
An acute illness characterised by sudden onset of fever 
with any of the following symptoms 
 headache, 
 backache, 
 photophobia, 
 severe arthralgia, 
 rash. 
8 
Acute Encephalitis 
Syndrome 
A person of any age, at any time of year with the acute 
onset of fever and a change in mental status 
(including symptoms such as confusion, disorientation, 
coma, or inability to talk) 
AND/OR 
New onset of seizures (excluding simple febrile 
seizures). 
(* Simple febrile seizure: a single seizure lasting < 15 
minutes with recovery of consciousness within 
60 minutes, in a child aged 6 months to 60 months). 
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9 
Meningitis 
(Old - 
*Meningococcal 
Disease and 
Viral Meningitis) 
Meningitis- 
An illness with sudden onset of fever (>38.5°C rectal or 
>38.0°C axillary), neck stiffness & one or 
9A 
* Meningitis 
(*  Meningococcal  
Disease  &  Viral 
Meningitis   to   be   
replaced   by 
Meningitis) 
more of the following: 
Headache 
Vomiting 
altered consciousness 
other meningeal sign 
petechial or purpural rash 
In patients <2 year, suspect meningitis when fever 
accompanied by bulging fontanelle. 
10 Measles 
A suspected measles case is any person in whom a 
health worker or clinician suspects measles or any 
person with fever and maculopapular rash (non-
vesicular) with cough or coryza or conjunctivitis. 
(Source –WHO) 
11 Mumps 
Acute onset of unilateral or bilateral parotitis or other 
salivary gland swelling lasting at least 2 days, or 
orchitis  
oophoritis unexplained by other apparent cause. 
(Source - WHO–recommended standards for 
surveillance of selected Vaccine-preventable diseases, 
February 
2003) added on 25/10/16, NCDC 
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12 Diphtheria 
An illness of the upper respiratory tract characterized 
by the following: 
laryngitis or pharyngitis or tonsillitis, 
and adherent membranes of tonsils, pharynx and/or 
nose. 
(Source: Immunization Handbook for Medical Officers, 
MOHFW) 
13 Pertussis 
A person meeting the clinical manifestation* of 
pertussis, with history of contact with a laboratory 
confirmed 
case of pertussis. 
Source –WHO–recommended standards for 
surveillance of selected vaccine-preventable diseases 
Feb 
2003 (modified on 25/10/16, NCDC) 
*Clinical manifestation of pertussis 
A person with a cough lasting at least two weeks with 
at least one of the following: 
i. Paroxysms (i.e. fits) of coughing 
ii. Inspiratory whooping 
iii. Post-tussive vomiting (i.e. vomiting immediately 
after coughing) 
iv. Without other apparent causes 
OR 
Apnea (with or without cyanosis) in infants (age <1 
year old) with cough of any duration 
OR 
If a specialist physician strongly suspects pertussis in a 
patient with cough of any duration. 
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14 Chickenpox 
A febrile illness with acute onset of diffuse 
(generalized) maculopapulo vesicular rash without 
other apparent cause. 
(Source: Manual for surveillance of Vaccine 
Preventable Diseases, 3rd Edition, 2002, CDC) 
15 
Fever of Unknown 
Origin (PUO) 
Fever of more than 101°F (38.3°C), either continuous 
or intermittent, for at least two weeks, 
Or 
Fever above 101°F with no known cause even after 
extensive diagnostic testing 
(Source: www.umm.edu/altmed/ articles/fever) 
16 
Acute Respiratory 
illness (ARI) / 
Influenza Like 
Illness (ILI) 
ILI:-An acute respiratory infection with measured 
fever of more than or equal to 38 C°and cough; 
with onset within the last 10 days. 
(Source: - WHO Global Epidemiological Surveillance 
Standards for Influenza 2014) 
SARI (Severe Acute Respiratory infection:- 
An acute respiratory infection with: 
  history of fever or measured fever of more than or 
equal to 38 C°; 
  and cough; 
  with onset within the last 10 days; 
 and requires hospitalization. 
(Source: - WHO Global Epidemiological Surveillance 
Standards for Influenza 2014) 
17 Pneumonia 
Any case clinically diagnosed as pneumonia with 
symptoms of fever and cough and/or difficult breathing 
± chest X-ray confirmation. 
Or 
In a child -  
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Pneumonia: Cough or difficult breathing and 
breathing rate >50/minute for infant 
aged 2 months to <1year 
breathing rate>40/minute for child aged 
1 to 5 years and with or without chest 
in drawing, stridor or danger signs 
18 Leptospirosis 
Acute febrile illness with headache, myalgia and 
prostration associated with a history of exposure to 
infected animals or an environment contaminated with 
animal urine with one or more of the following 
 Calf muscle tenderness 
 Conjunctival suffusion 
  Oliguria or anuria and/or proteinuria 
 Jaundice 
 Haemorrhagic manifestations (intestines, lung) 
 Meningeal irritation 
   GI symptoms ( Nausea/ Vomiting/ Abdominal 
pain/Diarrhoea) 
Source -Programme for Prevention and Control of 
Leptospirosis NCDC 2015 Operational Guidelines- 
(modified on 25/10/16, NCDC) 
19 
Acute Flaccid 
Paralysis 
A child under 15 years of age presenting with acute 
flaccid paralysis (AFP), 
Or 
any person at any age with paralytic illness if 
poliomyelitis is suspected. 
(Source: - WHO-recommended surveillance standard of 
poliomyelitis) 
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20 Kala Azar 
A ‘suspect’ case: history of fever of more than 2 weeks 
with splenomegaly & hepatomegaly not 
responding to anti-malarial and antibiotics in a patient 
from an endemic area 
Or 
A patient with above symptoms clinically examined by 
doctor and found positive on 
Screening with rapid diagnostic test. 
Or In cases with past history of Kala-azar or in those 
with high suspicion of Kala-azar but 
with negative RDT test result but found (+) by 
examination of bone marrow/spleen aspirate for LD 
bodies at appropriate level (district hospital). (Source – 
Kala Azar Guidelines NVBDCP 2015) 
21 Yellow Fever 
Suspect Case - A disease characterized by acute onset 
of fever followed by Jaundice within 2 weeks of onset 
of first symptoms and a history of travel in/transit 
through a yellow fever affected area within the last six 
days prior to the development of first symptoms 
(longest incubation period for yellow fever) with or 
without Haemorrhagic manifestations and signs of renal 
failure. 
22 Scrub Typhus 
A suspected #Clinical case with titres of 1:80* or above 
in OXK antigens by Weil Felix test. 
#-see the box below for reference 
* States can define their significant titres 
(Source – Modified (25.10.16) - Guidelines for 
diagnosis and management of Rickettsial diseases in 
India ICMR February 2015) 
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#Clinical case of Scrub Typhus is defined as: 
Acute undifferentiated febrile illness of 5 days or more 
with or without eschar should 
be suspected as a case of Rickettsial infection. (If 
eschar is present, fever of less than 5days duration 
should be considered as scrub typhus.) 
Other presenting features may be headache and rash, 
lymphadenopathy, multi-organ 
involvement like liver, lung and kidney involvement. 
The differential diagnosis of dengue, malaria, 
pneumonia, leptospirosis and typhoid 
should be kept in mind. 
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ANALYSIS &INTERPRETATION 
 
Data analysis: 
The data obtained was entered into Microsoft Excel. The data were 
reported as the mean +/- SD or the median ,depending on their 
distribution. 
The differences in quantitative variables between groups were 
assessed by means of unpaired t test. The chi square test was used to 
assess difference in categorical variables .A P value of < 0.05 was taken 
as significant for all statistical tests. All data were analysed with a 
statistical software package. (SPSS, version 16 for windows) 
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OBSERVATION AND RESULTS 
AGE  DISTRIBUTION 
 
S.No 
Age group 
No of children 
(n=50) 
Percent 
1 1 month - 1 year 8 16.0 
2 1 yr to 5 yr 19 38.0 
3 5 - 12 yr 23 46.0 
 
A total of 50 children with AKI were studied. Out of 50 children , tropical 
AKI was more common in 5-12 yr age group(46%) .There were 19 
children in the 1-5 yr age group(38%) and 8 children in 1month-1 
year(16%) age group (16%). 
 
1m-1yr
1yr-5yr
5yr-12yr
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GENDER  DISTRIBUTION 
 
 
Out of 50 children ,31(62%) were girls,19(38%) were males. 
  
male
38%
female
62%
S.No Gender No of children(n=50) Percentage 
1 male 19 38.0 
2 female 31 62.0 
 Total 50 100.0 
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PRESENTING COMPLAINTS 
 
Out of 50 children with AKI , 31 children(62%) were presented with the 
initial symptom of fever for more than 5 days duration,8 children (16%) 
had fever of less than 5 days duration,10 children (20%)had a history  of 
snake bite and 1 child  had scorpion sting (2%).This was a statistically  
significant association between fever and AKI ( P value < 0.05) 
S.NO 
Presenting 
complaints 
No of children  
(n=50) 
Percentage 
1 fever < 5 days 8 16.0 
2 fever > 5 days 31 62.0 
3 snake bite 10 20.0 
4 scorpion 1 2.0 
0
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Association of AKI   with abdominal pain 
 
 
S.NO Abdomen pain 
No of children 
(n=50) 
Percentage 
 yes 20 40.0 
 no 30 60.0 
 
Out of 50 children with AKI, 30(60 %) children had no abdominal pain 
and 20 children (40%) presented with abdominal pain. However there 
was no statistically significant association between AKI and abdominal 
pain (P value > 0.05). 
  
1.5 times
63%
2 times
37%
 
 
65 
 
AKI BASED ON BLOOD UREA LEVELS 
 
S.no Blood urea levels Frequency Percent 
1 40-100 26 52.0 
2 100-150 24 48.0 
 
AKI was more common in children with blood urea values between 40-
100 (52%) compared to levels more than 100 (48%). There was no 
statistically significant association between AKI and blood urea values 
(0.826). 
40-100 100-150
26
24
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AKI Based on serum creatinine levels 
 
Serum creatinine level found to be elevated to 3 times the normal in the 
children who had AKI. 
 
 
 
 
0 10 20 30 40
1.5 times
2 times
3 times 40%
22%
38%
Sno 
Serum creatinine 
level 
Frequency Percentage 
1 1.5 times 19 38.0 
2 2 times 11 22.0 
3 3 times 20 40.0 
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Out of 50 children with AKI,20children(40%) had serum  creatinine 
elevation 3 times  from baseline , 11 children (22%) had serum creatinine 
elevation 2 times from baseline,19 children(38%) had serum creatinine 
elevation 1.5 times elevated from baseline. A statistically significant 
association was found between elevated serum creatinine levels and acute 
kidney injury. 
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AKI based on URINE OUTPUT 
 
 
Duration of fever and 
history of envenomation 
pRIFLE criteria based on urine 
output 
Total 
Risk 
(n=20) 
Injury 
(n=13) 
Failure 
(n=17) 
FEVER 
fever < 5 days 3 1 4 8 
fever > 5 days 14 7 10 31 
snake bite 3 5 2 10 
Scorpion 0 0 1 1 
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ASSOCIATION BETWEEN DURATION OF FEVER /HISTORY 
OF ENVENOMATION & URINE OUTPUT 
AKI  based on urine output as per  RIFLE  criteria 
 40 % children in RISK category 
 34% Children in Failure category  
 26% children in Injury category 
The results were compared using chi square test and the P value found to 
significant (p value < 0.02). 
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NEED FOR DIALYSIS 
 
 
S.no 
Need for peritoneal 
dialysis 
No of 
children(n=50) 
Percentage 
Valid 
Percent 
Cumulativ
e Percent 
1 YES 23 46.0 46.0 46.0 
2 NO 27 54.0 54.0 100.0 
 
  
46%
54%
peritoneal dialysis
yes no
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NO OF CYCLES OF PERITONEAL DIALYSIS 
No of cycles 
of PD 
Frequency Percent Valid Percent 
Cumulative 
Percent 
<60 22 44.0 44.0 44.0 
>60 1 2.0 2.0 46.0 
3 27 54.0 54.0 100.0 
 
Out of 50 children with AKI, 23(46%) children needed dialysis and 
27(54%) children did not need dialysis. The results were compared using 
chi square and the p value found to be 0.65. However these results were 
not found to be statistically significant (P value 0.65). 
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COMORBIDITIES 
 
 
S no Co morbidity No of children(n=50) Percent 
1 sepsis 22 44.0 
2 others 10 20.0 
3 none 18 36.0 
 
Sepsis was the most common co-morbidity associated with AKI (44 %) 
this result was found to be statistically significant. 
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AKI ETIOLOGICAL PROFILE 
 
  
  
0
5
10
15
20
25
30
35
40
45
pneumonia diptheria dengue acute
encephalitis
leptospirosis enteric fever snake bite scorpian
sting
 
 
74 
 
  
S.No Etiology of AKI Frequency Percent 
1 Pneumonia 4 8.0 
2 Diphtheria 1 2.0 
3 Dengue 20 40.0 
4 Acute encephalitis 6 12.0 
5 Leptospirosis 2 6.0 
6 Enteric fever 6 12.0 
7 Snake bite 9 18.0 
8 Scorpion sting 1 2.0 
 
Out of 50 children with AKI, 20 children had Dengue fever (40 %), 
9(18%) children had snake bite,6(12%) children had acute 
encephalitis,6(12%) had enteric fever 4 (8%) children had pneumonia,2 
children had leptospirosis and 1 had scorpion sting. These results were 
found to be statistically significant (P value 0.03). 
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OUTCOME OF AKI 
 
S no AKI outcome Frequency Percent 
1 RECOVERED 40 80.0 
2 DIED 10 20.0 
 
Among 50 people with AKI, 40(80%) recovered and 10(20%) died and 
the P value found to be 0.045 which was found to be statistically 
significant. 
  
Recovered
Died
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AKI : OUTCOME and AGE 
 
OUTCOME 
AGE 
Total 1 month - 1 
year 
1 yr to 5 yr 5 - 12 yr 
RECOVERED 6 15 19 40 
DIED 2 4 4 10 
Total 8 19 23 50 
 
Recovery was 23 % in 5-12 year age group:  among the 8 children aged 1 
month-1 year 6 were recovered, 2 died. This was found to be statically 
significant (P value=0.01) 
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Clinical Outcome & Urine output as per RIFLE Criteria;
 
S no Clinical outcome 
Urine output as per RIFLE 
criteria 
Total 
Risk 
(n=20) 
Injury 
(13) 
Failure 
(n=17) 
1 RECOVERED 20 11 9 40 
2 DIED 0 2 8 10 
 
When urine output was considered, 20 children with urine output in RISK 
criteria recovered;9 children in FAILURE criteria recovered.11 children 
in INJURY criteria recovered. 
No child in RISK criteria died 2 children in INJURY criterion and 8 
children in FAILURE criterion died. 
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Clinical Outcome correlation with need of dialysis 
OUTCOME * DIALYSIS Cross tabulation 
OUTCOME 
DIALYSIS 
Total 
RECOVERED 
Peritoneal 
Dialysis 
No Need for 
dialysis 
15 25 40 
DIED 8 2 10 
Total 23 27 50 
 
Out of 50 children 23 children need peritoneal dialysis and among 
them,15 recovered & 8 children were died. In 27 children there was no 
need for dialysis, but 2 of them died. 
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Outcome with  Serum Creatinine 
 
CLINICAL OUTCOME &SERUM CREATININE LEVEL 
Sno 
Clinical 
Outcome 
SERUM CREATININE LEVEL 
Total 
1.5 times N 2 times N 3 times N 
 
RECOVERE
D 19 9 12 40 
DIED 0 2 8 10 
Total 19 11 20 50 
 
Those children with serum creatinine 1.5 times elevated from the baseline 
had more recovery than those children with serum creatinine3 times from 
the baseline. 
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Clinical outcome & Diagnosis 
 
 DIAGNOSIS 
Clinical 
outcome 
pn
eu
m
on
ia
 
di
pt
he
ria
 
de
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en
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ric
 fe
ve
r 
sn
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e 
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Sc
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St
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g 
to
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l 
RECOVE
RED 2 1 17 3 2 6 9 0 40 
DIED 2 0 3 3 1 0 0 1 10 
4 1 20 6 2 6 9 1 50  
 
AKI caused by snake bite had remarkable  recovery followed by dengue 
fever. However these results were not statistically significant. 
(P value=0.606) 
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Clinical Outcome and Categorization as per p RIFLE 
 
 
 
OUTCOME  pRIFLE Cross tabulation 
 RIFLE(n=50) 
Total 
Sno Clinical outcome Injury(n=7) 
Risk(N=2
2) 
Failure(N=
21) 
1 RECOVERED 6 22 12 40 
2 DIED 1 0 9 10 
 
Out of 50 children with AKI, 22 children in RISK criterion,7 children in 
INJURY criterion, 21 children in FAILURE criterion according to p 
RIFLE criteria  More children belonging to the recovery than children in 
FAILURE category. This was found to be statistically significant. 
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DISCUSSION 
Various studies done on tropical febrile illness reported a wide 
range of incidence of AKI from 4.5% to 70%.In a study done by Naik S 
et al, the incidence of AKI was 40.9%.In a study done by Mehta et al,  the 
incidence of AKI was 36.1%.the present study showed that 12.5% of 
them developed AKI, which was significant and similar to various other 
studies. Different definitions of AKI account for some of the reported 
significant  differences in the incidence of AKI. 
AKI was more common in the 5-12year of age group. A higher 
proportion of AKI among this may be due to the higher prevalence of 
tropical infections in this age group due to more mobility. 
 Lower proportion of AKI among 1month-1year may be due to 
maternal immunity in infants as well as less mobility. This concurs with 
the study done by Panwars et al which showed that AKI was common in 
5-12 years. The study conducted by panwar s et al shows that the 
incidence of AKI was more common in 5-12years 
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This result was in contrast to the result proposed by Maqbool and 
Mehta et al who found that AKI more common in the below 1 year of age 
group. 
In the present study, AKI was more common in female children 
[31%] compared to males children , This is in contrast to the study 
conducted by panwar s et al which states that males were predisposed to 
more renal dysfunction than females. 
In the present study, AKI was more common in the children, who 
initially presented with fever of more than 5 days duration [62%] and this 
was statistically significant. 
 Hence the duration of fever has on impact on acute kidney injury 
and this result is concurs with the study conducted by Sonnet et al and 
Panwar s et al. 
Abdominal pain presentation as a presenting feature has no 
association. 
Those children who did not present with abdominal pain  
developed  AKI[60%] as compared to children who presented with 
abdominal pain. 
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Among the AKI cases ,serum creatinine levels and urine output 
criteria were applied in all cases. Risk(R),Injury(I), Failure cases were  
20(40%), 13(26%), 17(34%) respectively as per pRIFLE based on urine 
output levels. As per serum creatinine criteria, prevalence of stage R was 
19(38%), I was 11(22%) and F was 40% respectively. 
AKI based on urine output criteria, maximum number of children 
were in Risk criterion and this was due to prerenal cause. But when AKI 
was considered, applying serum creatinine criteria,this may be serum 
creatinine is insensitive and delayed measure of decreased kidney 
function following AKI.(P value was 0.045)  
Among 50 children with AKI, 23 children(46%) needed dialysis 
and 27 children(54%) did not need  dialysis. This is probably  due to 
prerenal cause which improved by early recognition and treatment. 
Sepsis was the major comorbidity associated with acute kidney 
injury and this result connects with study conducted by Maqbool and 
Mehta and Krishnamurthy et al. 
Tropical AKI was common in children with blood urea value of40-
100mg/dl and the P value was 0.826   However, there was no statistical 
significance . 
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In the present study, the most common cause of tropical AKI was 
Dengue(40%) 
The other causes were 
 Snake bite (18%), 
 Acute encephalitis (12%), 
 Pneumonia (8%), 
 Enteric fever (12%), 
 Leptospirosis (6%), 
 Scorpion sting (2%)  
 Diphtheria (2%) 
Dengue fever was the most common cause of AKI induced by 
tropical febrile illness. Panwar et al reported that malaria as the common 
cause of AKI in the tropics. This may be attributed to   geographical 
variations & disease trend. 
Among 50 children, 40 children recovered and 10 died. Recovery 
of AKI was more in age group of 5-12years.Eventhough the incidence of 
AKI was more common in 5-12 years age group, recovery rate was also 
high. 
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In Children with AKI according to urine output and serum 
creatinine criteria the recovery rate was more in Risk criteria, this is 
probably due to the pre renal nature cause of AKI. 
Outcome is good in children, when there is no need for dialysis and 
this is due to sepsis complicated by invasive procedure and other co-
morbidity. 
Snake bite induced AKI had more recovery followed by AKI 
caused by dengue fever. 
More no of Children in Risk criterion recovered than those in 
failure criteria. 
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SUMMARY 
 This cohort study found that proportion of AKI was 12.5 % 
 The maximum number of AKI in the children 5-12 years aged 
 AKI were more common in females 
 Tropical AKI was more common in children when they initially 
presented with fever for more than 5 days 
 Abdominal pain presentation had no correlation with AKI 
 Most of the children with tropical AKI according to urine output 
criteria by p RIFLE were in Risk criteria followed by failure 
criteria. 
 According to serum creatinine criteria, most of the children in 
failure criteria. Sepsis was the most common co-morbidity 
associated with AKI 
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 The most common etiology associated with Tropical AKI was 
dengue. 
 5-12 year children with tropical AKI had more recovery 
 RISK criteria children according to both urine output and serum 
creatinine criteria had more recovery. 
 Recovery rate was more in non dialysis children 
 Snake bite associated AKI had more recovery 
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CONCLUSION 
Since the incidence of tropical AKI on the rise and  it is under 
diagnosed. Early screening for AKI by using this pRIFLE may prevent 
the progression of AKI from Risk to Injury . 
Early initiation of treatment goes a long way in prevention of AKI. 
Improvement in environmental sanitation and community health Prevent 
Dengue fever which is the major cause of AKI (Dengue) in the present 
study. Early recognition and initiation of treatment will cause 100% 
recovery from AKI. Bacterial sepsis is the most common co-morbidity 
associated with AKI. 
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ANNEXURES - PROFORMA  
INCIDENCE,CLINICO PATHOLOGICAL AND BIOCHEMICAL 
PROFILE AND IMMEDIATE OUTCOME OF INFANTS AND 
CHILDREN WITH TROPICAL ACUTE KIDNEY INJURY 
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CONSENT FORM 
I have come to know that Dr. R. NIVETHIDHA, Postgraduate in the 
Department of Paediatrics is conducting a study on the topic "A STUDY ON 
INCIDENCE / CLINICAL SPECTRUM / BIOCHEMICAL PROFILE 
AND IMMEDIATE OUTCOME IN INFANTS AND CHILDREN WITH 
TROPICAL ACUTE KIDNEY INJURY IN A TERTIARY CARE 
HOPSITAL"  I understand that my child will not have to suffer anyharmful 
consequences as a result of the study nor will I have any financial constraints. 
It is understood that blood will be collected from my child for the 
purpose of conductingthis study. 
I also understand that I can withdraw myself from this study at any point 
oftime and by doing so it will not affect the treatment in any manner. 
Understanding allthese, I wholeheartedly agree to take part in this study. 
 
Signature 
Name of the guardian: 
Relation: 
 
 
Place: 
Date: 
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1 RATHISH 1 1 1 2 2 2 3 B C 1 1 2 1 4 PNEUMONIA 2 2 2 2 2 2 FAILURE     
2 VIMAL 3 1 2 2 2 2 2 A B 1 1 2 1 4 DIPTHERIA 2 2 2 2 2 2 INJURY THROAT PAIN   
3 SHANMUGA PRIYA 3 2 1 2 2 2 2 B A 2 2 2   4 DENGUE 1 2 2 2 2 2 INJURY     
4 YATHRA 1 2 1 2 2 2 3 B C 1 1 2 1 4 
ACUTE 
ENCEPHALITIS 
1 2 2 2 2 2 FAILURE SEIZURES DIED 
5 SAKTHIVEL 3 1 2 2 2 2 3 A C 1 2 2   1 DENGUE 1 2 2 2 2 2 FAILURE   DIED 
6 SANJAY GANDHI 3 1 1 2 2 2 3 B C 1 1 2 1 4 
ACUTE 
ENCEPHALITIS 
2 2 2 2 2 1 FAILURE SEIZURES DIED 
7 RESHMI KANTHAN 1 2 1 1 2 2 3 B B 1 1 2 1 1 PNEUMONIA 3 3 3 3 3 3 FAILURE   DIED 
8 RAMYA 3 2 2 2 2 2 1 A C 1 1 2 2 1 DENGUE 1 2 2 2 2 2 FAILURE     
9 SABareeshwari 3 2 2 1 2 2 3 B C 1 1 2 1 4 
ACUTE 
ENCEPHALITIS 
1 2 2 3 3 2 FAILURE   DIED 
10 SIVAKUMAR 3 1 2 1 2 2 2 A B 1 1 2 1 5 DENGUE 1 2 2 2 2 2 INJURY     
11 NIVETHA 3 2 2 2 2 2 1 A A 2 2 2   4 LEPTOSPIROSIS 2 2 1 2 2 2 RISK SKIN RASH   
12  FRANK PIO 2 1 2 1 2 2 3 B C 1 1 2 1 4 DENGUE 1 2 2 3 2 2 INJURY     
13 PRANAV 2 1 2 2 2 2 3 B C 1 1 2 1 4 
ACUTE 
ENCEPHALITIS 
2 2 2 2 2 2 FAILURE SEIZURES   
14 vibinesh 2 1 2 1 2 2 1 A A 2 2 2   5 ENTERIC FEVER 2 1 2 2 2 2 RISK     
15 SHANMATHA 3 2 3 2 1 2 3 B C 1 1 2 1 5 SNAKE BITE 3 3 3 3 3 3 FAILURE     
16 DHARMENDRAN 2 2 1 1 2 2 1 A A 2 2 2   5 DENGUE 1 2 2 2 2 2 RISK     
17 MADHIVANAN 1 1 2 1 2 2 1 A A 2 2 2   5 DENGUE 1 2 2 2 2 2 RISK     
18 KAVIN KUMAR 3 2 3 2 1 2 1 A A 2 2 2   5 SNAKE BITE 3 3 3 3 3 3 RISK     
19 ABROSE BEGAM 3 2 2 1 2 2 1 A A 2 2 2   5 DENGUE 1 2 2 2 2 2 RISK     
20 DHAMODRAN 3 1 2 2 2 2 1 A A 2 2 2   5 DENGUE 1 2 2 2 2 2 RISK     
21 SUDHIKSHA 2 2 2 2 2 2 1 A A 2 2 2   1 DENGUE 1 2 2 2 2 2 RISK     
22 JOSHIKA 3 2 2 2 2 2 1 B B 1 1 2 1 1 
ACUTE 
ENCEPHALITIS 
2 22 2 2 2 2 FAILURE     
23 UMAMAHESHWARI 2 2 2 2 2 2 1 A A 2 2 2   1 PNEUMONIA 2 2 2 3 3 3 RISK     
24 SUBASHREE 1 2 2 2 2 2 1 A A 2 2 2     ENTERIC FEVER 2 1 2 2 2 2 RISK     
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25 HARISH 1 2 1 2 2 2 1 A A 2 2 2   4 
ACUTE 
ENCEPHALITIS 
2 3 3 3 3 3 RISK     
26 KARTHIKEYAN 2 1 2 1 2 2 3 B C 2 1 2 1 1 DENGUE 1 2 2 2 2 2 FAILURE     
27 HEMANTH 2 1 2 1 2 2 1 A A 2 2 2   1 ENTERIC FEVER 2 1 2 2 2 2 RISK     
28 ANUSUYA 3 2 3 2 1 2 2 B B 1 1 2 1 5 SNAKE BITE 3 3 3 3 3 3 FAILURE     
29 ABINAYA 3 2 2 1 2 2 2 B C 1 2 2   1 DENGUE 1 2 2 2 2 2 FAILURE SEIZURES DIED 
30 ANJALI 3 2 3 1 1 2 2 A B 2 2 2   5 SNAKE BITE 3 3 3 3 3 3 INJURY CELLULITIS   
31 NIRANJAN 2 2 2 1 2 2 2 A B 1 1 2 1 1 DENGUE 1 2 2 2 2 2 INJURY     
32 SIVAKUMAR 2 2 2 2 2 2 3 B C 1 1 2 1 1 DENGUE 1 2 2 2 2 2 INJURY   DIED 
33 HARIDEV 1 2 1 2 2 2 1 A A 2 2 2   1 ADD 3 3 3 3 3 3 RISK 
VOMITING, 
LOOSESTOOLS 
  
34 YOGAMITHRA 3 2 2 1 2 2 1 A A 2 2 2   5 DENGUE 1 2 2 2 2 2 RISK     
35 CHARUMATHY 2 2 3 2 1 2 1 A A 2 2 2     SNAKE BITE 3 3 3 3 3 3 RSK     
36 LYRAHANNE 3 2 3 2 2 2 2 B C 1 1 2 1 1 DENGUE 1 2 2 2 2 2 RISK     
37 GAYATHRI 3 2 3 2 1 2 2 B C 1 1 2 1 5 SNAKE BITE 3 3 3 3 3 3 FAILURE     
38 KAVIN KUMAR 2 1 2 2 2 2 3 B C 1 1 2 1 1 PNEUMONIA 2 3 3 3 3 3 FAILURE   DIED 
39 CHINNAPONNU 2 2 3 2 1 2 3 B C 1 1 2 1 5 SNAKE BITE 3 3 3 3 3 3 FAILURE   RECOVERED 
40 VIBINAKASH 3 1 2 1 2 2 1 A A 2 2 2   5 ENTERIC FEVER 2 1 2 2 2 2 RISK     
41 ANUSUYA 2 2 2 1 2 2 3 B C 1 1 1 2 1 DENGUE 1 2 2 2 2 2 FAILURE   RECOVERED 
42 MOHAMMED INAS 1 1 2 1 2 2 3 B C 1 1 2 1 1 DENGUE 1 2 2 2 2 2 FAILURE     
43 BOOTAMAL 2 2 3 1 2 1 3 B C 1 1 2 1 5 SCORPIAN STING 3 3 3 3 3 3 FAILURE   DIED 
44 NISHANTH 3 1 2 1 2 2 3 B C 1 1 1 2 1 DENGUE 1 2 2 2 2 2 FAILURE   RECOVERED 
45 VIBINESH 2 1 2 1 2 2 2 B B 1 1 2 1 1 LEPTOSPIROSIS 2 2 1 2 2 2 FAILURE   DIED 
46 VIMAL 2 1 3 2 1 2 2 B B 1 2 1   5 SNAKE BITE 3 3 3 3 3 3 RISK     
47 GAVASKAR 3 1 2 2 2 2 1 A A 2 2 2   5 ENTERIC FEVER 2 1 2 2 2 2 RISK     
48 RAMYA 2 2 3 2 1 2 1 A A 2 2 2   5 SNAKE BITE 3 3 3 3 3 3 RISK     
49 GAYATHRI 2 2 2 2 2 2 2 A B 1 2 2   1 DENGUE 1 2 2 2 2 2 RISK     
50 LAVANYA 3 2 2 2 2 2 2 A B 2 2 2   1 ENTERIC FEVER 2 1 2 2 2 2 RISK     
 
 
 
